ACURA PHARMACEUTICALS, INC (ACUR) has 130 open-market insider trades by 20 insiders since 2008. The most active filer is William G. Skelly, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Capital Investments Ii Lp Care | 10% | — | 15 | $5.7M | 2014-02-28 |
| Capital Offshore Investments Ii Lp Care | 10% | — | 9 | $5.3M | 2013-06-06 |
| Capital Ii Llc Care | 10% | — | 15 | $4.0M | 2013-07-15 |
| GALEN Partners III L P | — | — | 7 | $2.1M | 2017-12-14 |
| Partners International Iii L. P. Galen | 10% | — | 6 | $1.4M | 2015-01-12 |
| Holdings Llc Gce | 10% | — | 8 | $1.0M | 2012-10-01 |
| Galen Management, LLC | 10% | — | 2 | $795K | 2014-02-28 |
| Llc Claudius | 10% | — | 6 | $786K | 2015-01-12 |
| Richard J. Markham | Dir | — | 8 | $766K | 2010-03-05 |
| Employee Fund Iii Lp Galen | 10% | — | 5 | $620K | 2015-06-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert B. Jones | President | Buy | $40K | 2017-12-14 |
| Robert A. Seiser | VP & Controller | Buy | $30K | 2017-12-14 |
| George K. Ross | Director | Buy | $5K | 2017-12-14 |
| Bruce F. Wesson | Director | Buy | $34K | 2017-12-14 |
| GALEN Partners III L P | — | Sell | $439K | 2017-12-14 |
| William G. Skelly | Director | Buy | $10K | 2017-12-14 |
Companies that share insiders with ACUR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Albert W. Brzeczko | VP | Buy | $6K | 2017-08-25 |
| Employee Fund Iii Lp Galen | 10% | Sell | $113K | 2015-06-16 |
| Partners International Iii L. P. Galen | 10% | Sell | $106K | 2015-01-08 |
| William G. Skelly | Director | Sell | $6K | 2014-05-22 |
| William G. Skelly | Director | Sell | $6K | 2014-05-20 |
| Albert W. Brzeczko | VP Technical Affairs - APT | Buy | $2K | 2014-05-19 |
| J. Bradley Rivet | VP Marketing | Buy | $2K | 2014-05-19 |
| Peter A. Clemens | Senior VP and CFO | Buy | $4K | 2014-05-16 |
| James F. Emigh | VP Corporate Development | Buy | $18K | 2014-05-16 |